Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.

Gastberger S, Baumgartner MR, Soyka M, Quednow BB, Hulka LM, Herdener M, Seifritz E, Mutschler J.

Eur Addict Res. 2019;25(4):207-212. doi: 10.1159/000500542. Epub 2019 May 8.

PMID:
31067528
2.

Stigma as a Barrier to Mental Health Service Use Among Female Sex Workers in Switzerland.

Zehnder M, Mutschler J, Rössler W, Rufer M, Rüsch N.

Front Psychiatry. 2019 Feb 5;10:32. doi: 10.3389/fpsyt.2019.00032. eCollection 2019.

3.

Gut microbiomes of mobile predators vary with landscape context and species identity.

Tiede J, Scherber C, Mutschler J, McMahon KD, Gratton C.

Ecol Evol. 2017 Sep 12;7(20):8545-8557. doi: 10.1002/ece3.3390. eCollection 2017 Oct.

4.

A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.

Florek NW, Kamlangdee A, Mutschler JP, Kingstad-Bakke B, Schultz-Darken N, Broman KW, Osorio JE, Friedrich TC.

PLoS One. 2017 Aug 3;12(8):e0181738. doi: 10.1371/journal.pone.0181738. eCollection 2017.

5.

Telecommunications Network Measurements of Online Gambling Behavior in Switzerland: A Feasibility Study.

Bitar R, Nordt C, Grosshans M, Herdener M, Seifritz E, Mutschler J.

Eur Addict Res. 2017;23(2):106-112. doi: 10.1159/000471482. Epub 2017 Apr 13.

6.

Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.

Soyka M, Kranzler HR, Hesselbrock V, Kasper S, Mutschler J, Möller HJ; WFSBP Task Force on Treatment Guidelines for Substance Use Disorders.

World J Biol Psychiatry. 2017 Mar;18(2):86-119. doi: 10.1080/15622975.2016.1246752. Epub 2016 Dec 23. Review.

PMID:
28006997
7.

Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication.

Ericsen AJ, Lauck M, Mohns MS, DiNapoli SR, Mutschler JP, Greene JM, Weinfurter JT, Lehrer-Brey G, Prall TM, Gieger SM, Buechler CR, Crosno KA, Peterson EJ, Reynolds MR, Wiseman RW, Burwitz BJ, Estes JD, Sacha JB, Friedrich TC, Brenchley JM, O'Connor DH.

PLoS Pathog. 2016 Dec 7;12(12):e1006048. doi: 10.1371/journal.ppat.1006048. eCollection 2016 Dec.

8.

Pregabalin Use Among Opioid-Addicted Patients in Switzerland.

Mutschler J, Gastberger S, Baumgartner MR, Grosshans M, Seifritz E, Quednow BB, Herdener M.

J Clin Psychiatry. 2016 Sep;77(9):1202-1203. doi: 10.4088/JCP.15l10296. No abstract available.

9.

The association of pineal gland volume and body mass in obese and normal weight individuals: a pilot study.

Grosshans M, Vollmert C, Vollstaedt-Klein S, Nolte I, Schwarz E, Wagner X, Leweke M, Mutschler J, Kiefer F, Bumb JM.

Psychiatr Danub. 2016 Sep;28(3):220-224.

10.

Correction for Dinis et al., Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.

Dinis JM, Florek NW, Fatola OO, Moncla LH, Mutschler JP, Charlier OK, Meece JK, Belongia EA, Friedrich TC.

J Virol. 2016 Aug 12;90(17):8029. doi: 10.1128/JVI.01041-16. Print 2016 Sep 1. No abstract available.

11.

[Pharmacological prophylactic treatment for relapse of alcohol dependence : Results of current meta-analyses].

Mutschler J, Soyka M.

Nervenarzt. 2017 Mar;88(3):303-307. doi: 10.1007/s00115-016-0133-x. German. No abstract available.

PMID:
27278059
12.

["Food addiction" as a possible risk factor for obesity].

Frey L, Riva M, Grosshans M, Mutschler J.

Praxis (Bern 1994). 2016 Mar 30;105(7):397-404. doi: 10.1024/1661-8157/a002309. Review. German.

PMID:
27005734
13.

Current Findings and Mechanisms of Action of Disulfiram in the Treatment of Alcohol Dependence.

Mutschler J, Grosshans M, Soyka M, Rösner S.

Pharmacopsychiatry. 2016 Jul;49(4):137-41. doi: 10.1055/s-0042-103592. Epub 2016 Mar 17. Review.

PMID:
26987743
14.

Selective Bottlenecks Shape Evolutionary Pathways Taken during Mammalian Adaptation of a 1918-like Avian Influenza Virus.

Moncla LH, Zhong G, Nelson CW, Dinis JM, Mutschler J, Hughes AL, Watanabe T, Kawaoka Y, Friedrich TC.

Cell Host Microbe. 2016 Feb 10;19(2):169-80. doi: 10.1016/j.chom.2016.01.011.

15.

Measuring substance misuse in trafficked people.

Hulka L, Mutschler J.

Lancet Psychiatry. 2016 Feb;3(2):e11. doi: 10.1016/S2215-0366(15)00580-5. No abstract available.

PMID:
26851332
16.

Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.

Dinis JM, Florek NW, Fatola OO, Moncla LH, Mutschler JP, Charlier OK, Meece JK, Belongia EA, Friedrich TC.

J Virol. 2016 Jan 6;90(7):3355-65. doi: 10.1128/JVI.03248-15. Erratum in: J Virol. 2016 Aug 12;90(17 ):8029.

17.

Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine.

Soyka M, Mutschler J.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:148-61. doi: 10.1016/j.pnpbp.2015.11.003. Epub 2015 Nov 12. Review.

PMID:
26577297
18.

Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection.

Bailey AL, Lauck M, Mohns M, Peterson EJ, Beheler K, Brunner KG, Crosno K, Mejia A, Mutschler J, Gehrke M, Greene J, Ericsen AJ, Weiler A, Lehrer-Brey G, Friedrich TC, Sibley SD, Kallas EG, Capuano S 3rd, Rogers J, Goldberg TL, Simmons HA, O'Connor DH.

Sci Transl Med. 2015 Sep 16;7(305):305ra144. doi: 10.1126/scitranslmed.aab3467.

19.

Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.

Dürsteler KM, Berger EM, Strasser J, Caflisch C, Mutschler J, Herdener M, Vogel M.

Subst Abuse Rehabil. 2015 Jun 17;6:61-74. doi: 10.2147/SAR.S50807. eCollection 2015. Review.

20.

Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience.

Grosshans M, Mutschler J, Kiefer F.

Int Clin Psychopharmacol. 2015 Jul;30(4):237-8. doi: 10.1097/YIC.0000000000000069.

PMID:
25647453
21.

[Substance abuse in older adults].

Bitar R, Dürsteler KM, Rösner S, Grosshans M, Herdener M, Mutschler J.

Praxis (Bern 1994). 2014 Sep 3;103(18):1071-9. doi: 10.1024/1661-8157/a001777. Review. German.

PMID:
25183616
22.

Comparative single-cell genomics reveals potential ecological niches for the freshwater acI Actinobacteria lineage.

Ghylin TW, Garcia SL, Moya F, Oyserman BO, Schwientek P, Forest KT, Mutschler J, Dwulit-Smith J, Chan LK, Martinez-Garcia M, Sczyrba A, Stepanauskas R, Grossart HP, Woyke T, Warnecke F, Malmstrom R, Bertilsson S, McMahon KD.

ISME J. 2014 Dec;8(12):2503-16. doi: 10.1038/ismej.2014.135. Epub 2014 Aug 5.

23.

Intraperitoneal atrial natriuretic peptide attenuates anxiety-related behaviour during alcohol withdrawal in mice.

von der Goltz C, Jahn H, Mutschler J, Wiedemann K, Kiefer F.

Pharmacopsychiatry. 2014 May;47(3):97-100. doi: 10.1055/s-0034-1372645. Epub 2014 May 20.

PMID:
24846084
24.

Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients.

Grosshans M, Mutschler J, Luderer M, Mann K, Kiefer F.

Clin Neuropharmacol. 2014 Jan-Feb;37(1):6-8. doi: 10.1097/WNF.0000000000000007.

25.

Treatment of severe sleep disorder related to alcohol-dependence with high-dose agomelatine - a case report.

Grosshans M, Mutschler J, Kiefer F.

Psychiatr Danub. 2013 Dec;25(4):416-8. No abstract available.

26.

Pregabalin abuse among opiate addicted patients.

Grosshans M, Lemenager T, Vollmert C, Kaemmerer N, Schreiner R, Mutschler J, Wagner X, Kiefer F, Hermann D.

Eur J Clin Pharmacol. 2013 Dec;69(12):2021-5. doi: 10.1007/s00228-013-1578-5. Epub 2013 Aug 30.

PMID:
23989299
27.

Functional polymorphism in the neuropeptide Y gene promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women.

Mutschler J, Abbruzzese E, Wiedemann K, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, Majic T, Petrovsky N, Thuerauf N, Kornhuber J, Gründer G, Rademacher L, Brinkmeyer J, Wienker T, Wagner M, Winterer G, Kiefer F.

Ann Nutr Metab. 2013;62(4):271-6. doi: 10.1159/000346799. Epub 2013 May 4.

28.

[Mechanism of action of disulfiram and treatment optimization in prevention of recurrent alcoholism].

Mutschler J, Kiefer F.

Praxis (Bern 1994). 2013 Jan 30;102(3):139-46. doi: 10.1024/1661-8157/a001178. Review. German.

PMID:
23384983
29.

Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case-control study.

Mutschler J, Abbruzzese E, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, Majic T, Petrovsky N, Thuerauf N, Kornhuber J, Gründer G, Rademacher L, Brinkmeyer J, Wienker T, Wagner M, Winterer G, Kiefer F.

Nicotine Tob Res. 2013 Jul;15(7):1322-7. doi: 10.1093/ntr/nts334. Epub 2013 Jan 3.

PMID:
23288874
30.

Insula-specific H magnetic resonance spectroscopy reactions in heavy smokers under acute nicotine withdrawal and after oral nicotine substitution.

Gutzeit A, Froehlich JM, Hergan K, Graf N, Binkert CA, Meier D, Brügger M, Reischauer C, Sutter R, Herdener M, Schubert T, Kos S, Grosshans M, Straka M, Mutschler J.

Eur Addict Res. 2013;19(4):184-93. doi: 10.1159/000345915. Epub 2012 Dec 15.

31.

Differential NMR spectroscopy reactions of anterior/posterior and right/left insular subdivisions due to acute dental pain.

Gutzeit A, Meier D, Froehlich JM, Hergan K, Kos S, V Weymarn C, Lutz K, Ettlin D, Binkert CA, Mutschler J, Sartoretti-Schefer S, Brügger M.

Eur Radiol. 2013 Feb;23(2):450-60. doi: 10.1007/s00330-012-2621-0. Epub 2012 Sep 12.

PMID:
22968781
32.

Functional polymorphism of the dopamine β-hydroxylase gene is associated with increased risk of disulfiram-induced adverse effects in alcohol-dependent patients.

Mutschler J, Abbruzzese E, Witt SH, Dirican G, Nieratschker V, Frank J, Grosshans M, Rietschel M, Kiefer F.

J Clin Psychopharmacol. 2012 Aug;32(4):578-80. doi: 10.1097/JCP.0b013e31825ddbe6. No abstract available.

PMID:
22760354
33.

Circulating ghrelin levels are not associated with craving and withdrawal symptoms in acute nicotine withdrawal.

Mutschler J, Graf N, Spanaus KS, Rössler W, Hergan K, Binkert CA, Gutzeit A.

Psychiatr Danub. 2012 Jun;24(2):229-30. No abstract available.

34.

Application of electronic diaries in patients with schizophrenia and bipolar disorders.

Mutschler J, von Zitzewitz F, Rössler W, Grosshans M.

Psychiatr Danub. 2012 Jun;24(2):206-10.

35.

Functional social support within a medical supervised outpatient treatment program.

Mutschler J, Eifler S, Dirican G, Grosshans M, Kiefer F, Rössler W, Diehl A.

Am J Drug Alcohol Abuse. 2013 Jan;39(1):44-9. doi: 10.3109/00952990.2012.677889. Epub 2012 May 17.

PMID:
22594669
36.

Genetic variation in the neuropeptide Y gene promoter is associated with increased risk of tobacco smoking.

Mutschler J, Abbruzzese E, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, Majic T, Petrovsky N, Kornhuber J, Thuerauf N, Gründer G, Brinkmeyer J, Wienker T, Wagner M, Winterer G, Kiefer F.

Eur Addict Res. 2012;18(5):246-52. doi: 10.1159/000338276. Epub 2012 May 15.

37.

Association of leptin with food cue-induced activation in human reward pathways.

Grosshans M, Vollmert C, Vollstädt-Klein S, Tost H, Leber S, Bach P, Bühler M, von der Goltz C, Mutschler J, Loeber S, Hermann D, Wiedemann K, Meyer-Lindenberg A, Kiefer F.

Arch Gen Psychiatry. 2012 May;69(5):529-37. doi: 10.1001/archgenpsychiatry.2011.1586.

PMID:
22566584
38.

Agomelatine for Depression in Schizophrenia: A Case-Series.

Mutschler J, Rüsch N, Schönfelder H, Herwig U, Brühl AB, Grosshans M, Rössler W, Russmann H.

Psychopharmacol Bull. 2012 Feb 15;45(1):35-43.

39.

Growing fatty mass in the back: diagnosis of a multiple symmetric lipomatosis (Madelung's disease) in association with chronic alcoholism.

Gutzeit A, Binkert CA, Schmidt S, Jandali AR, Mutschler J, Hergan K, Kos S.

Skeletal Radiol. 2012 Apr;41(4):465-6, 489-90. doi: 10.1007/s00256-011-1281-5. Epub 2011 Nov 11. No abstract available.

PMID:
22075714
40.

Safety and efficacy of long-term disulfiram aftercare.

Mutschler J, Dirican G, Gutzeit A, Grosshans M.

Clin Neuropharmacol. 2011 Sep-Oct;34(5):195-8. doi: 10.1097/WNF.0b013e3182285e2d.

PMID:
21881495
41.

Experienced acetaldehyde reaction does not improve treatment response in outpatients treated with supervised disulfiram.

Mutschler J, Dirican G, Funke S, Obermann C, Grosshans M, Mann K, Kiefer F, Diehl A.

Clin Neuropharmacol. 2011 Jul-Aug;34(4):161-5. doi: 10.1097/WNF.0b013e3182216fd5.

PMID:
21677573
42.

Pregabalin-induced suicidal ideations.

Mutschler J, Grosshans M, Herwig U, Heekeren K, Kawohl W, Brühl A.

Pharmacopsychiatry. 2011 May;44(3):119. doi: 10.1055/s-0031-1271689. Epub 2011 Feb 11. No abstract available.

PMID:
21318939
43.

Enzyme catalysis with small ionic liquid quantities.

Fischer F, Mutschler J, Zufferey D.

J Ind Microbiol Biotechnol. 2011 Apr;38(4):477-87. doi: 10.1007/s10295-010-0908-1. Epub 2010 Nov 24. Review.

PMID:
21107639
44.

The natriuretic peptide system as a possible therapeutic target for stress-induced obesity.

Mutschler J, Kiefer F.

Med Hypotheses. 2011 Mar;76(3):388-90. doi: 10.1016/j.mehy.2010.10.049. Epub 2010 Nov 23. Review.

PMID:
21106300
45.

Urinary ethylglucuronide assessment in patients treated with disulfiram: a tool to improve verification of abstention and safety.

Mutschler J, Grosshans M, Koopmann A, Mann K, Kiefer F, Hermann D.

Clin Neuropharmacol. 2010 Nov-Dec;33(6):285-7. doi: 10.1097/WNF.0b013e3181fc9362.

PMID:
20975547
46.

Effect of a microemulsion system on hapten-peptide reactivity studies: examples of hydroxycitronellal and citral, fragrance skin sensitizers, with glutathione.

Merckel F, Bernard G, Mutschler J, Giménez-Arnau E, Gerberick GF, Lepoittevin JP.

Chem Res Toxicol. 2010 Sep 20;23(9):1433-41. doi: 10.1021/tx100043b.

PMID:
20795681
47.

Dextromethorphan withdrawal and dependence syndrome.

Mutschler J, Koopmann A, Grosshans M, Hermann D, Mann K, Kiefer F.

Dtsch Arztebl Int. 2010 Jul;107(30):537-40. doi: 10.3238/arztebl.2010.0537. Epub 2010 Jul 30.

48.

Quetiapine-induced hyperventilation and dyspnea.

Mutschler J, Obermann C, Grosshans M.

Clin Neuropharmacol. 2010 Jul;33(4):214. doi: 10.1097/WNF.0b013e3181e1cc51.

PMID:
20661028
49.

[Impact of functional social support for abstinence after inpatient detoxification].

Mutschler J, Kobiella A, Grosshans M, Kiefer F.

Neuropsychiatr. 2010;24(2):118-24. German.

PMID:
20605007
50.

Pregabalin abuse, dependence, and withdrawal: a case report.

Grosshans M, Mutschler J, Hermann D, Klein O, Dressing H, Kiefer F, Mann K.

Am J Psychiatry. 2010 Jul;167(7):869. doi: 10.1176/appi.ajp.2010.09091269. No abstract available.

PMID:
20595436

Supplemental Content

Loading ...
Support Center